1548.HK - Genscript Biotech Corporation

HKSE - HKSE Delayed Price. Currency in HKD
20.600
-0.950 (-4.41%)
At close: 4:08PM HKT
Stock chart is not supported by your current browser
Previous Close21.550
Open21.800
Bid20.500 x 0
Ask20.600 x 0
Day's Range20.300 - 21.800
52 Week Range9.430 - 31.700
Volume12,784,253
Avg. Volume7,770,189
Market Cap38.192B
Beta (3Y Monthly)2.34
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2017-06-05
1y Target Est4.50
  • Reuters5 months ago

    Amgen antibody shows promise in myeloma trial, gets FDA fast track

    Amgen Inc (AMGN.O), updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. Six patients were still responding at 7.5 months of follow-up, according to research presented in San Diego at the annual meeting of the American Society of Haematology (ASH). Amgen said AMG420, which targets a protein linked to multiple myeloma known as BCMA, has been given fast track status by the U.S. Food and Drug Administration.

  • Hong Kong Biotech Stock Suddenly Loses Almost Half its Value
    Bloomberg7 months ago

    Hong Kong Biotech Stock Suddenly Loses Almost Half its Value

    A Chinese biotech stock suddenly plunged as much as 47 percent in Hong Kong, attracting more turnover in the morning session than most stocks do in an entire day. While Genscript Biotech Corp. had pared losses to 27 percent before trading was suspended at 11:32 a.m., the decline wiped off about $1 billion from the company’s market value. Local media cited a bearish report from an anonymous research group that was shared on Chinese social media, though it wasn’t available on the group’s own website.

  • Genscript Biotech Corporation (HKG:1548) Has Attractive Fundamentals, Here’s Why
    Simply Wall St.10 months ago

    Genscript Biotech Corporation (HKG:1548) Has Attractive Fundamentals, Here’s Why

    I’ve been keeping an eye on Genscript Biotech Corporation (HKG:1548) because I’m attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believeRead More...

  • Reuters10 months ago

    BRIEF-Genscript Biotech Corp Says Unit Entered MoU With Innovation Center For Immune Therapy Of Tsinghua University

    June 18 (Reuters) - Genscript Biotech Corp: * GENSCRIPT BIOTECH CORP Says UNIT ENTERED MOU WITH INNOVATION CENTER FOR IMMUNE THERAPY OF TSINGHUA UNIVERSITY FOR DISCOVERY & DEVELOPMENT OF BIOLOGICS Source ...

  • PR Newswire11 months ago

    Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple Myeloma

    LCAR-B38M CAR-T therapy (JNJ-68284528) to be developed as part of strategic partnership between Legend and Janssen PISCATAWAY, N.J. , May 30, 2018 /PRNewswire/ -- Legend Biotech, a subsidiary of GenScript ...

  • Top SEHK High Growth Stock
    Simply Wall St.11 months ago

    Top SEHK High Growth Stock

    Companies such as YiChang HEC ChangJiang Pharmaceutical and Essex Bio-Technology have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolioRead More...

  • April Growth Stock Picks
    Simply Wall St.last year

    April Growth Stock Picks

    High growth companies such as Essex Bio-Technology and Genscript Biotech has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companies tendRead More...